Evidence map›Paper›PMID 29997084›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2018

[Generation of a new strain of NOD/SCID/IL2Rγ

Ya-Chen Liu, Qu Chen, Xing-Long Yang, Qing-Shuang Tang, Kai-Tai Yao, Yang Xu

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ya-Chen LiuGuangdong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China. E-mail: raoxia920927@hotmail.com.
Qu Chen
Xing-Long Yang
Qing-Shuang Tang
Kai-Tai Yao
Yang Xu
Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe NOD/SCID/IL2Rγ

methodsTargeted disruption of Prkdc and IL2Rγ genes was achieved using the CRISPR/Cas9 system. By intercrossing the knockout and NOD mice, we obtained a novel strain of NOD/SCID/IL2Rγ

resultsIn addition to the NOD mutation, cNSG mice exhibited a complete absence of T cells, B cells and NK cells. cNSG mice allowed more efficient engraftment of human cancer cells than the commonly used immunodeficient nude mice.

conclusioncNSG mice will provide an important xenotransplantation model for biomedical research.

Indexed as

CRISPR-Cas SystemsTransplantation, HeterologousAnimalsB-LymphocytesDNA-Activated Protein KinaseDNA-Binding ProteinsInterleukin Receptor Common gamma SubunitKiller Cells, NaturalMiceMice, Inbred NODMice, KnockoutMice, NudeMice, SCIDModels, AnimalNuclear ProteinsSelective BreedingDNA-Activated Protein KinaseDNA-Binding ProteinsInterleukin Receptor Common gamma SubunitNuclear ProteinsPrkdc protein, mouse

Identifiers

PMID29997084
PMCPMC6765701
OpenAlexW2886202944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.